State of Alaska Department of Revenue’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.9M Buy
53,574
+8,447
+19% +$250K 0.02% 723
2026
Q1
$1.25M Buy
45,127
+1,775
+4% +$45.6K 0.01% 970
2025
Q4
$940K Sell
43,352
-2,575
-6% -$50.8K 0.01% 1110
2025
Q3
$694K Sell
45,927
-1,363
-3% -$16.9K 0.01% 1263
2025
Q2
$532K Sell
47,290
-2,000
-4% -$21.7K 0.01% 1348
2025
Q1
$497K Buy
49,290
+325
+0.7% +$3.52K 0.01% 1363
2024
Q4
$579K Sell
48,965
-1,710
-3% -$20.2K 0.01% 1331
2024
Q3
$584K Buy
50,675
+13,675
+37% +$156K 0.01% 1340
2024
Q2
$391K Hold
37,000
﹤0.01% 1450
2024
Q1
$389K Buy
+37,000
New +$399K ﹤0.01% 1467

Other funds holding ROIV

State of Alaska Department of Revenue's ROIV Position: Q2 2026 in Review

State of Alaska Department of Revenue increased its Roivant Sciences (ROIV) stake by 19% in Q2 2026, buying an estimated $250K and bringing the position to 53,574 shares worth $1.9M. The position accounts for 0.02% of the portfolio, ranked #723.

State of Alaska Department of Revenue first reported a position in ROIV in Q1 2024 and has held it in 10 quarters since. 499 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • State of Alaska Department of Revenue held 53,574 shares of Roivant Sciences worth $1.9M as of Q2 2026.
  • State of Alaska Department of Revenue bought 8,447 Roivant Sciences shares in Q2 2026, an estimated $250K.
  • Roivant Sciences made up 0.02% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #723 holding.
  • State of Alaska Department of Revenue first reported a position in Roivant Sciences in Q1 2024 and has held it in 10 quarters since.
  • 499 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.